Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Drukarch

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Behavioural Pharmacology|April 26, 2000
The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958G Andringa, L Lubbers, B Drukarch, et al.
Free Radical Biology & Medicine|August 1, 1995
Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slicesC H Langeveld, E Schepens, J C Stoof, et al.
Brain Research|January 24, 1998
Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiencyB Drukarch, E Schepens, C A Jongenelen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1996
Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson's diseaseB Drukarch, C A Jongenelen, E Schepens, et al.
British Journal of Pharmacology|September 1, 1989
Restricted usefulness of tetraethylammonium and 4-aminopyridine for the characterization of receptor-operated K+-channelsB Drukarch, K S Kits, J E Leysen, et al.
European Journal of Pharmacology|January 27, 1999
The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptorsG Andringa, B Drukarch, J E Leysen, et al.
Free Radical Biology & Medicine|July 17, 1998
Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen speciesB Drukarch, E Schepens, J C Stoof, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 28, 2005
The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytesB Drukarch, J Flier, C A M Jongenelen, et al.
Brain Research. Developmental Brain Research|March 16, 1995
Effects of chronic activation of dopamine D-2 receptors in cultures of rat fetal dopaminergic neurons: indications for alterations in functional activityF L Van Muiswinkel, C A Jongenelen, H T Schepens, et al.
Synapse (New York, N.Y.)|July 1, 1994
Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptorsA N Schoffelmeer, F Hogenboom, A H Mulder, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Behavioural Pharmacology|April 26, 2000
The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958G Andringa, L Lubbers, B Drukarch, et al.
Free Radical Biology & Medicine|August 1, 1995
Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slicesC H Langeveld, E Schepens, J C Stoof, et al.
Brain Research|January 24, 1998
Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiencyB Drukarch, E Schepens, C A Jongenelen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1996
Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson's diseaseB Drukarch, C A Jongenelen, E Schepens, et al.
British Journal of Pharmacology|September 1, 1989
Restricted usefulness of tetraethylammonium and 4-aminopyridine for the characterization of receptor-operated K+-channelsB Drukarch, K S Kits, J E Leysen, et al.
European Journal of Pharmacology|January 27, 1999
The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptorsG Andringa, B Drukarch, J E Leysen, et al.
Free Radical Biology & Medicine|July 17, 1998
Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen speciesB Drukarch, E Schepens, J C Stoof, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 28, 2005
The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytesB Drukarch, J Flier, C A M Jongenelen, et al.
Brain Research. Developmental Brain Research|March 16, 1995
Effects of chronic activation of dopamine D-2 receptors in cultures of rat fetal dopaminergic neurons: indications for alterations in functional activityF L Van Muiswinkel, C A Jongenelen, H T Schepens, et al.
Synapse (New York, N.Y.)|July 1, 1994
Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptorsA N Schoffelmeer, F Hogenboom, A H Mulder, et al.
Pageof 6